Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Journal of Translational Medicine|February 23, 2005
A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancerMichael A Morse, Jennifer Garst, Takuya Osada, et al.
Vaccine|October 18, 2011
Increasing vaccine potency through exosome antigen targetingZachary C Hartman, Junping Wei, Oliver K Glass, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|December 5, 2019
Immune correlates of clinical benefit in a phase I study of hyperthermia with adoptive T cell immunotherapy in patients with solid tumorsGuoliang Qiao, Xiaoli Wang, Xinna Zhou, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|November 24, 2024
Synchronized autologous T-cell immunotherapy with hyperthermia to previously heavy treated advanced renal cell carcinomaJun Ren, Congcong Li, Dazhao Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
Phase I study utilizing a novel antigen-presenting cell-targeted vaccine with Toll-like receptor stimulation to induce immunity to self-antigens in cancer patientsMichael A Morse, Robert Chapman, John Powderly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2017
Dendritic Cell/Cytokine-Induced Killer Cell Immunotherapy Combined with S-1 in Patients with Advanced Pancreatic Cancer: A Prospective StudyNi Jiang, Guoliang Qiao, Xiaoli Wang, et al.
Infectious Agents and Cancer|April 9, 2025
Clinical impact of concurrent autologous adoptive T cells immunotherapy in active COVID-19 infected cancer patients for chemotherapyCongcong Li, Dazhao Xu, Linyao Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
An adenoviral vaccine encoding full-length inactivated human Her2 exhibits potent immunogenicty and enhanced therapeutic efficacy without oncogenicityZachary C Hartman, Junping Wei, Takuya Osada, et al.
Molecular Cancer Therapeutics|October 22, 2021
HSP90-Specific nIR Probe Identifies Aggressive Prostate Cancers: Translation from Preclinical Models to a Human Phase I StudyTakuya Osada, Erika J Crosby, Kensuke Kaneko, et al.
Science Immunology|December 19, 2025
CD27 agonism enhances long-lived CD4 T cell vaccine responses critical for antitumor immunityBin-Jin Hwang, Erika J Crosby, David T Severson, et al.
Pageof 4